As cannabis medicine becomes more advanced, so does our understanding of how cannabinoids interact with the body’s ...

A receptor that cannabis latches onto in the brain could be a promising target for future mental health treatments. Experiencing chronic stress is known to leave people vulnerable to depression or ...

Cannabinoid CB1 receptors have been a potential target for nonopioid-based pain treatment, but actually targeting the pathway has been hindered by issues with tolerance and unwanted CNS side effects.

Here at A3, we believe in equal opportunity. We recognize that saying we have an addiction problem is not the same as saying we have a drug use problem and that just because some people abuse ...

A new study shows that prenatal disruption of the endocannabinoid system can have long-lasting effects on brain structure and ...

When faced with chronic stress, why do some people develop anxiety and depressive symptoms while others show resilience? The results of studies in mice, headed by researchers at Université Laval, ...

The efficacy of cannabinoid CB1 receptor antagonists in diet-induced obesity and its related metabolic complications is well established, but they are tied to central nervous system (CNS)-related ...

Endocannabinoids are similar to the cannabinoids present in cannabis, but they are found naturally in the body. Endocannabinoids—and cannabinoids—work through a signaling system that supports ...

This Phase 1b study was previously conducted by Bird Rock Bio, Inc., which Skye acquired in 2023.

If there aren’t enough reasons already, add more leafy greens to your diet. Research has shown that leafy greens rich with the terpene beta-caryophyllene activate the CB2 receptor in mice models. Beta ...